GLP-1 weight loss, prescribed and monitored by a physician
Semaglutide and tirzepatide programs paired with eligibility screening, dosing guidance, and ongoing lab monitoring — not a one-time prescription with no follow-up.
What we prescribe
Semaglutide
A GLP-1 receptor agonist administered by weekly injection to reduce appetite and support gradual, sustained weight loss.
Tirzepatide
A dual GIP/GLP-1 receptor agonist, also weekly, for patients who may benefit from a dual-pathway approach.
Medication choice is made individually with Dr. Jean-Pierre based on your health history, goals, and response to treatment — not a fixed package.
How the program works
Common questions
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GLP-1 and GIP receptors. Both reduce appetite and support weight loss; Dr. Jean-Pierre will recommend one based on your history, goals, and response to treatment.
Do I need insurance to start treatment here?
No. This is a direct-pay practice. Visits are billed per appointment, no insurance filing, using card, Zelle, Cash App, or PayPal.
How is my eligibility determined?
Eligibility is based on a full medical history, current medications, and relevant lab work, reviewed during your consultation.
What does ongoing monitoring look like?
Scheduled follow-ups to review progress, adjust dosing, and order labs as needed. Labs are not drawn in-office; orders go to Quest Diagnostics or a lab of your choice.
How much does treatment cost?
Cost depends on the medication, dose, and visit frequency your plan requires. Book a consultation for a personalized quote before starting treatment.